A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic Pain
Study Identifier
M11-891
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
Phase
Phase 2
Sex
Female & Male
Age
18 - 75 Years
Protocol Summary
People with diabetes can, over time develop nerve damage throughout the body with symptoms such as pain, tingling, or numbness (loss of feeling) in the hands, arms, feet and legs.
Study Locations
Location
Status
Location
Site Reference ID/Investigator# 51807
Little Rock, Arkansas, United States, 72204
Status
Not applicable
Location
Site Reference ID/Investigator# 51946
Anaheim, California, United States, 92801
Status
Not applicable
Location
Site Reference ID/Investigator# 51468
Long Beach, California, United States, 90806
Status
Not applicable
Location
Site Reference ID/Investigator# 52744
Walnut Creek, California, United States, 94598
Status
Not applicable
Location
Site Reference ID/Investigator# 51079
Clearwater, Florida, United States, 33765
Status
Not applicable
Location
Site Reference ID/Investigator# 51076
Hialeah, Florida, United States, 33012
Status
Not applicable
Showing {first} - {last} of {total} Results